Skip to content

Microcirculation & ASICs

Study of the Cutaneous Microcirculation: ASIC Involvement.

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01246180
Enrollment
20
Registered
2010-11-23
Start date
2010-10-31
Completion date
2010-12-31
Last updated
2019-05-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Physiological Conditions

Keywords

Skin, microcirculation; ASIC, pressure ulcer

Brief summary

Pressure ulcers are a common and costly problem. Advancing the understanding regarding the basic pathophysiological mechanisms mediating the development of pressure ulcers will allow for better delineation of populations at risk. Healthy skin is protected from pressure-induced ischemic damage because of the presence of pressure-induced vasodilation (PIV). In contrast, in absence of PIV, such as in diabetic patients or older subjects with sensory neuropathy, the skin is exposed to severe cutaneous ischemia, which could lead to pressure ulcer formation. Since Acid Sensing Ion channels (ASICs) appear to be involved in the cutaneous mechanosensitivity, the investigators hypothesized that PIV could be altered by treatments that block ASICs.

Interventions

DRUGDiclofenac

diclofenac 5% vs placebo (topical application) cutaneous blood flow measurement using laser Doppler

DRUGAmiloride

amiloride 1mM vs placebo (intradermal injection) cutaneous blood flow measurement using laser Doppler

Sponsors

Hospices Civils de Lyon
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
BASIC_SCIENCE
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 40 Years
Healthy volunteers
Yes

Inclusion criteria

* Healthy adult males or females aged between 18 and 40 years of age

Exclusion criteria

* no consent, diabetes, neuropathy.

Design outcomes

Primary

MeasureTime frame
evaluate the difference in the cutaneous microvascular response to local pressure application between treated (amiloride and diclofenac) and untreated skin.Criteria will be measured 30 and 60 minutes following the injection of amiloride and the application of diclofenac, respectively.

Secondary

MeasureTime frame
Evaluate difference in the cutaneous sensitivity and the cutaneous microvascular response to acetylcholine, sodium nitroprusside, electrical current and local heating between treated (amiloride and diclofenac) and untreated skinCriteria will be measured 30 and 60 minutes following the injection of amiloride and the application of diclofenac, respectively.

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026